Home › Funds › Blue Owl Capital Holdings LP › ENGNW

Blue Owl Capital Holdings LP position in ENGNW

ENGENE THERAPEUTICS INC · Materials

Blue Owl Capital Holdings LP reported holding 511,177 shares of ENGNW (ENGENE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$102K, representing 0.02% of its reported portfolio and ranking #46 among its reported holdings. Blue Owl Capital Holdings LP has disclosed ENGNW holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)511.18K sh
Reported value held$102.29K
Portfolio Weight0.02%
First reportedQ4 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's ENGNW position evolved

Blue Owl Capital Holdings LP first disclosed a stake in ENGNW in Q4 2023 at 475,077 shares (US$404K). The position peaked in Q1 2024 at 511,177 shares, worth US$2.7M. Across 12 filings, Blue Owl Capital Holdings LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 511,177 shares valued at US$102K. Notable position changes include a 899% increase in Q3 2024, a 93% trim in Q4 2024, a 1316% increase in Q1 2026.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 475.08K $403.81K New
Q1 2024 511.18K $2.66M Add
Q2 2024 51.18K $608.30K Reduce
Q3 2024 511.18K $728.43K Add
Q4 2024 36.10K $30.44K Reduce
Q1 2025 36.10K $21.67K Hold
Q2 2025 36.10K $29.60K Hold
Q3 2025 36.10K $25.63K Hold
Q4 2025 36.10K $102.89K Hold
Q1 2026 511.18K $1.29M Add
Q2 2026 511.18K $148.19K Hold
Q3 2026 511.18K $102.29K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENGNW and 13F data

ENGNW (ENGENE THERAPEUTICS INC) is a Materials company. 11 other funds we track also report a position in ENGNW — the largest reported positions include FCPM III SERVICES B.V. (US$834K), BVF INC/IL (US$274K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENGNW

All ENGNW fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held ENGNW?

Blue Owl Capital Holdings LP has disclosed ENGNW holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Blue Owl Capital Holdings LP's current position in ENGNW?

As of Q3 2026, Blue Owl Capital Holdings LP holds 511.18K shares of ENGNW (ENGENE THERAPEUTICS INC), valued at $102.29K, representing 0.02% of its reported portfolio and ranking #46.

Has Blue Owl Capital Holdings LP been buying or selling ENGNW?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP held unchanged its position in ENGNW. The position peaked in Q1 2024 at 511.18K shares.

Which other funds hold ENGNW?

Other major institutional holders of ENGNW include FCPM III SERVICES B.V., BVF INC/IL, among 11 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.